Literature DB >> 14732849

[Epidemiology and management of care of hepatitis C infection in the Poitou-Charentes region in 1997 and 2000].

Eloi Blanchet1, Gautier Defossez, Alain Verneau, Isabelle Ingrand, Christine Silvain, Michel Beauchant.   

Abstract

OBJECTIVES: A repeat cross-sectional survey was performed in 1997 and 2000 in the Poitou-Charentes district of France to compare screening and management of hepatitis C virus infection.
METHODS: The "Hepatitis C Network" asked the biological laboratories in the region to provide anonymous results of serology tests performed during two two month periods at a 3 year interval. An epidemiological and follow-up questionnaire was sent to the medical practitioner who prescribed the test for all positive tests.
RESULTS: More serology tests were prescribed in 2000 (7074) than in 1997 (6168). The access to screening differed significantly between the 4 counties of the district (P<0.0001). Sixty-nine and 58 patients were first diagnosed respectively in 1997 and 2000. In 2000, these patients were younger (P=0.05) and were infected later (P=0.03). The risk factors were similar for the two periods. Respectively 23% and 26% underwent a liver biopsy, and 12% were treated.
CONCLUSION: Screening improved after a press campaign, but there was no increase in the number of newly detected patients. In 2000, one third of patients were still inadequately cared for.

Entities:  

Mesh:

Year:  2003        PMID: 14732849

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  2 in total

1.  Access to treatment of hepatitis C in prison inmates.

Authors:  Paul Strock; Joël Mossong; Karine Hawotte; Vic Arendt
Journal:  Dig Dis Sci       Date:  2008-08-29       Impact factor: 3.199

Review 2.  Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis.

Authors:  Esther Jane Aspinall; Joseph Samuel Doyle; Stephen Corson; Margaret Elena Hellard; David Hunt; David Goldberg; Tim Nguyen; Yngve Falck-Ytter; Rebecca Lynn Morgan; Bryce Smith; Mark Stoove; Stefan Zbyszko Wiktor; Sharon Hutchinson
Journal:  Eur J Epidemiol       Date:  2014-11-11       Impact factor: 8.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.